Inbrija (LEVODOPA)
Inbrija (LEVODOPA) is one of 8,063 medications in the MedPlain dataset. Key details — Brand name: Inbrija; Generic name: LEVODOPA; Drug class: Aromatic Amino Acid [EPC].
| Brand name | Inbrija |
|---|---|
| Generic name | LEVODOPA |
| Drug class | Aromatic Amino Acid [EPC] |
| Manufacturer | Merz Pharmaceuticals, LLC |
| Used for | 1 INDICATIONS AND USAGE INBRIJA is indicated for the intermittent treatment of OFF episodes in patients with Parkinson's disease treated with carbidopa/levodopa. INBRIJA is an aromatic amino acid indicated for the intermittent treatment of OFF episodes in patients with Parkinson's disease treated with carbidopa/levodopa ( 1 ) |
| Dosage | 2 DOSAGE AND ADMINISTRATION INBRIJA capsules are for oral inhalation only and should be used only with the INBRIJA inhaler. For oral inhalation only. DO NOT swallow INBRIJA capsules. Only use INBRIJA capsules with the INBRIJA inhaler ( 2.1 ) Inhale the contents of two INBRIJA capsules (84 mg) as needed for OFF symptoms, up to 5 times daily ( 2.2 ) The maximum dose per OFF period is 84 mg, and the maximum recommended daily dosage of INBRIJA is 420 mg ( 2.2 ) 2.1 Important Administration Instructi |
| Active ingredient(s) | LEVODOPA |
| Route | RESPIRATORY (INHALATION) |
| Official label | https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=077c0f39-a3a2-4b2b-a184-09131889dcfb |